GLUCOPYRANOSIDE COMPOUND
    21.
    发明申请
    GLUCOPYRANOSIDE COMPOUND 有权
    葡萄糖苷化合物

    公开(公告)号:US20120058941A1

    公开(公告)日:2012-03-08

    申请号:US13174814

    申请日:2011-07-01

    摘要: A compound of the formula: wherein Ring A and Ring B are: (1) Ring A is an optionally substituted unsaturated monocyclic heterocyclic ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring, (2) Ring A is an optionally substituted benzene ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring or an optionally substituted unsaturated fused heterobicyclic ring, or (3) Ring A is an optionally substituted unsaturated fused heterobicyclic ring, and Ring B are independently an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring; X is a carbon atom or a nitrogen atom; Y is —(CH2)n— (n is 1 or 2); or a pharmaceutically acceptable salt thereof, or a prodrug thereof.

    摘要翻译: 下式的化合物:其中环A和环B是:(1)环A是任选取代的不饱和单环杂环,环B是任选取代的不饱和单环杂环,任选取代的不饱和稠合杂双环,或 任选取代的苯环,(2)环A是任选取代的苯环,环B是任选取代的不饱和单环杂环或任选取代的不饱和稠环杂双环,或(3)环A是任选取代的不饱和稠合杂双环 环和环B独立地是任选取代的不饱和单环杂环,任选取代的不饱和稠合杂双环或任选取代的苯环; X是碳原子或氮原子; Y为 - (CH 2)n - (n为1或2); 或其药学上可接受的盐,或其前药。

    S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
    26.
    发明授权
    S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof 失效
    S型2-取代羟基-2-吲哚哩啶基丁酸酯化合物及其制备方法

    公开(公告)号:US06277992B1

    公开(公告)日:2001-08-21

    申请号:US09570172

    申请日:2000-05-12

    IPC分类号: C07D47112

    摘要: A process for preparing S type 2-substituted hydroxy-2-indolidinyl-butyric ester compound [II]: wherein R0 is residue of nitrogen-containing fused heterocyclic carboxylic acid having absolute configuration of “R”(in which the nitrogen atom is protected), R1 and R2 are lower alkyl group, and E is ester residue, which is useful as an intermediate for preparing camptothecin derivatives having antitumor activities, which comprises 2-ethylating 2-substituted hydroxy-2-indolidinylacetic ester compound [I]: wherein the symbols are as defined above.

    摘要翻译: 一种制备S型2-取代羟基-2-吲哚哩啶基 - 丁酸酯化合物[II]的方法:其中R 0是具有绝对构型“R”(其中保护氮原子)的含氮稠合杂环羧酸的残基, R 1和R 2为低级烷基,E为酯残基,其可用作制备具有抗肿瘤活性的喜树碱衍生物的中间体,其包括2-乙基化2-取代的羟基-2-吲哚哩啶基乙酸酯化合物[I]:其中 符号如上所述。